Montserrat Farnos Sabate is an experienced professional in the pharmaceutical industry, currently serving as a Feasibility Strategist at Bayer since March 2007, with previous roles including CLM Specialized in Feasibility process and CRA II/CLM. Prior to joining Bayer, Montserrat worked as an Investigadora in the Immunology Service at Hospital Clínic de Barcelona from 2002 to 2007 and contributed to a peptide chemistry research project at CSIC de Barcelona from 2000 to 2002. Montserrat holds a Master's degree in Clinical Trials from ESAME Pharmaceutical Business School (2006-2007) and a degree in Pharmacy with a focus on Immunology from Universitat de Barcelona (1995-2000).